WHO ICTRP trial

The benefits of early inotropic administration compared to refractory phase…

ISRCTN40192699 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN40192699
Public title The benefits of early inotropic administration compared to refractory phase inotropic administration in pediatric patients with septic shock
Scientific title Improvement of serum ferritin levels with inotropic administration in early phase compared to refractory phase in pediatric patients with septic shock: a preliminary randomized controlled trial study
Primary sponsor Udayana University
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase III/IV
Countries Indonesia
Conditions Improvement in the outcome of pediatric patients with septic shock by early administration of inotropic Infections and Infestations
Interventions Pediatric patients who first came to the paediatric ED in Prof. dr. IGNG Ngoerah Hospital in the study period of December 2019 until December 2020 with a diagnosis of septic shock according to the history, physical examination, as well as a…
Registration date Jan 26, 2023
Target size 13
Secondary IDs Nil known;Nil known;C4 277
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations